These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 29073812)
21. Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. Kiani AN; Wu T; Fang H; Zhou XJ; Ahn CW; Magder LS; Mohan C; Petri M J Rheumatol; 2012 Jun; 39(6):1231-7. PubMed ID: 22505707 [TBL] [Abstract][Full Text] [Related]
22. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study. Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621 [TBL] [Abstract][Full Text] [Related]
23. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis. Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775 [TBL] [Abstract][Full Text] [Related]
24. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Hammad A; Mosaad Y; Elhanbly S; Youssef H; El Refaaey A; Elhusseini F; Bakr A Lupus; 2013 Apr; 22(5):486-91. PubMed ID: 23554037 [TBL] [Abstract][Full Text] [Related]
25. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Emad G; Al-Barshomy SM Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906 [TBL] [Abstract][Full Text] [Related]
26. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
27. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus. Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C Front Immunol; 2022; 13():885307. PubMed ID: 35720325 [TBL] [Abstract][Full Text] [Related]
29. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis. Dong XW; Zheng ZH; Ding J; Luo X; Li ZQ; Li Y; Rong MY; Fu YL; Shi JH; Yu LC; Wu ZB; Zhu P Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067 [TBL] [Abstract][Full Text] [Related]
30. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Meyer OC; Nicaise-Roland P; Cadoudal N; Grootenboer-Mignot S; Palazzo E; Hayem G; Dieudé P; Chollet-Martin S Arthritis Res Ther; 2009; 11(3):R87. PubMed ID: 19515233 [TBL] [Abstract][Full Text] [Related]
31. Association between urinary adiponectin level and renal involvement in systemic lupus erythematous. Loghman M; Haghighi A; Broumand B; Ataipour Y; Tohidi M; Marzbani C; Fakharran M Int J Rheum Dis; 2016 Jul; 19(7):678-84. PubMed ID: 24467624 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews. Guimarães JAR; Furtado SDC; Lucas ACDS; Mori B; Barcellos JFM PLoS One; 2022; 17(10):e0275016. PubMed ID: 36215243 [TBL] [Abstract][Full Text] [Related]
33. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of urinary monocyte chemoattractant protein-1 in evaluating the activity of lupus nephritis: a meta-analysis. Xia YR; Li QR; Wang JP; Guo HS; Bao YQ; Mao YM; Wu J; Pan HF; Ye DQ Lupus; 2020 May; 29(6):599-606. PubMed ID: 32208799 [No Abstract] [Full Text] [Related]
35. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491 [TBL] [Abstract][Full Text] [Related]
36. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus. Vincent FB; Kandane-Rathnayake R; Hoi AY; Slavin L; Godsell JD; Kitching AR; Harris J; Nelson CL; Jenkins AJ; Chrysostomou A; Hibbs ML; Kerr PG; Rischmueller M; Mackay F; Morand EF Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439 [TBL] [Abstract][Full Text] [Related]
37. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. Alzawawy A; Zohary M; Ablordiny M; Eldalie M Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368 [TBL] [Abstract][Full Text] [Related]